Prostate cancer (PCa) affects more than 190,000 men each year with ~10% of men diagnosed at ≤ 55 years, i.e., early onset (EO) PCa. Based on historical findings for other cancers, EO PCa likely reflects a stronger underlying genetic etiology
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PC) is a significant economic and health burden in the U.S. and Europe but its caus...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PCa) affects more than 190,000 men each year with ~10% of men diagnosed at ≤ 55 yea...
We assessed the evidence for association between 23 recently reported prostate cancer (PCa) variants...
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mo...
BACKGROUND: We assessed the evidence for association between 23 recently reported prostate cancer (P...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
Introduction Prostate cancer (PrCa) is the commonest non-cutaneous cancer in men in the UK. Epidemio...
Objective: To investigate the inherited mutations and their association with clinical features and t...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
SummaryEarly-onset prostate cancer (EO-PCA) represents the earliest clinical manifestation of prosta...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
BACKGROUND: Prostate-specific antigen (PSA) levels are influenced by genetic variation unrelated to ...
BACKGROUND: Rare germline mutations in DNA repair genes are associated with prostate cancer (PCa) pr...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PC) is a significant economic and health burden in the U.S. and Europe but its caus...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PCa) affects more than 190,000 men each year with ~10% of men diagnosed at ≤ 55 yea...
We assessed the evidence for association between 23 recently reported prostate cancer (PCa) variants...
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mo...
BACKGROUND: We assessed the evidence for association between 23 recently reported prostate cancer (P...
Among United States men, prostate cancer is the most commonly diagnosed cancer, and the second most ...
Introduction Prostate cancer (PrCa) is the commonest non-cutaneous cancer in men in the UK. Epidemio...
Objective: To investigate the inherited mutations and their association with clinical features and t...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
SummaryEarly-onset prostate cancer (EO-PCA) represents the earliest clinical manifestation of prosta...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 10...
BACKGROUND: Prostate-specific antigen (PSA) levels are influenced by genetic variation unrelated to ...
BACKGROUND: Rare germline mutations in DNA repair genes are associated with prostate cancer (PCa) pr...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
Prostate cancer (PC) is a significant economic and health burden in the U.S. and Europe but its caus...
Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countri...
DOI
Add to ORKG